Found 6 matching trials
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1,Chemotherapy and Target Therapy for Metastatic Colorectal Cancer PHASE2 To improve the survival in patients with microsatellite stable metastatic c...
Show More Learn More & Join Trial
PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer NA The purpose of this prospective, single-center, phase II study is to evalua...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal) NA This trial tests how well personalized ultra fractionated stereotactic adap...
Show More Location
University of California at Los Angeles
Learn More & Join Trial
PULSAR in Systemic Therapy for Pancreatic Cancer PHASE2 Pancreatic cancer remains one of the malignancies with the lowest survival ...
Show More Location
Samsung Medical Center
Learn More & Join Trial
PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM PHASE2 To explore Progression-Free-Survival(FPS) of PULSAR(personalized ultrafract...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
Perioperative FLOT(D) With Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Esophageal Cancer PHASE1 The goal of this clinical trial is to learn the safety of the addition of P...
Show More Location
University of Texas Southwestern Medical Center
Learn More & Join Trial